Try our Advanced Search for more refined results

Ranbaxy Bows To Sweeping Penalties From US

By Bibeka Shrestha (January 26, 2012, 1:21 PM EST) -- The U.S. government on Wednesday sought court approval of a consent decree that will hold generic drug maker Ranbaxy Laboratories Ltd. to unprecedented standards before it can again produce drugs for the U.S. market at four plants cited by the U.S. Food and Drug Administration for serious manufacturing violations....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!